DOP2017000134A - Formulaciones inyectables de paracetamol - Google Patents
Formulaciones inyectables de paracetamolInfo
- Publication number
- DOP2017000134A DOP2017000134A DO2017000134A DO2017000134A DOP2017000134A DO P2017000134 A DOP2017000134 A DO P2017000134A DO 2017000134 A DO2017000134 A DO 2017000134A DO 2017000134 A DO2017000134 A DO 2017000134A DO P2017000134 A DOP2017000134 A DO P2017000134A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- paracetamol
- injectable formulations
- administration
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a inyecciones intravenosas de bajo volumen de paracetamol o su sal farmacéuticamente aceptable y el método de preparación del mismo. Las formulaciones proporcionan una alta concentración de paracetamol o su sal farmacéuticamente aceptable en un sistema disolvente de la presente invención que puede administrarse no sólo a través de la vía de infusión intramuscular e intravenosa, sino también para la administración de bolo IV lento después de la dilución con fluidos acuosos hasta el volumen final de no más de 20 ml. Estas formulaciones inyectables permanecen estables y también son adecuadas para administración a través de una vía intravenosa lenta con efectos secundarios minimizados (tales como flebitis, dolor, etc.)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN4102MU2014 | 2014-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2017000134A true DOP2017000134A (es) | 2017-09-15 |
Family
ID=55022620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2017000134A DOP2017000134A (es) | 2014-12-20 | 2017-06-09 | Formulaciones inyectables de paracetamol |
Country Status (28)
Country | Link |
---|---|
US (1) | US20180000940A1 (es) |
EP (1) | EP3233055A1 (es) |
JP (1) | JP2017538762A (es) |
KR (1) | KR20170099911A (es) |
CN (1) | CN107205924A (es) |
AR (1) | AR103188A1 (es) |
AU (1) | AU2015365533A1 (es) |
BR (1) | BR112017012975B1 (es) |
CA (1) | CA2969303A1 (es) |
CL (1) | CL2017001629A1 (es) |
CO (1) | CO2017006268A2 (es) |
CU (1) | CU20170088A7 (es) |
DO (1) | DOP2017000134A (es) |
EA (1) | EA201791409A1 (es) |
EC (1) | ECSP17038668A (es) |
IL (1) | IL252729A0 (es) |
JO (1) | JO3689B1 (es) |
MA (1) | MA40599A1 (es) |
MD (1) | MD20170071A2 (es) |
MX (1) | MX2017008264A (es) |
PE (1) | PE20171305A1 (es) |
PH (1) | PH12017501005A1 (es) |
SG (1) | SG11201704435PA (es) |
TN (1) | TN2017000232A1 (es) |
TW (1) | TWI649097B (es) |
UA (1) | UA122136C2 (es) |
UY (1) | UY36466A (es) |
WO (1) | WO2016097899A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107229455B (zh) | 2016-03-24 | 2019-09-17 | 阿里巴巴集团控股有限公司 | 一种业务处理方法、装置及系统 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2751875B1 (fr) * | 1996-08-05 | 1998-12-24 | Scr Newpharm | Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation |
IT1301976B1 (it) | 1998-07-31 | 2000-07-20 | Angelini Ricerche Spa | Composizione farmaceutica iniettabile a base di paracetamolo |
IT1313579B1 (it) | 1999-07-30 | 2002-09-09 | Acraf | Composizione farmaceutica liquida a base di paracetamolo. |
ITMI20012135A1 (it) | 2001-10-16 | 2003-04-16 | Bioren S A | Soluzioni iniettabili pronte all'uso di paracetamolo |
MX2007014862A (es) * | 2005-05-27 | 2008-02-21 | Panacea Biotec Ltd | Composiciones inyectables y procedimiento para la preparacion de dichas composiciones. |
ES2334164T3 (es) * | 2005-12-15 | 2010-03-05 | Acusphere, Inc. | Procedimiento de preparacion de formulaciones farmaceuticas a base de particulas para administracion parenteral. |
WO2009047634A2 (en) | 2007-06-18 | 2009-04-16 | Combino Pharm, S.L. | Aqueous formulations of acetaminophen for injection |
US20110015273A1 (en) | 2008-01-17 | 2011-01-20 | Rajnarayana Kandhagatla | Stable pharmaceutical aqueous compositions |
BRPI0919796A2 (pt) * | 2008-10-09 | 2015-12-15 | Acraf | formulação farmacêutica líquida livre de açúcar, e, excipiente líquido livre de açucar farmaceuticamente aceitável |
CN102958519B (zh) * | 2010-06-30 | 2016-01-13 | 特罗伊卡药品有限公司 | 包含扑热息痛的药物组合物及其制备方法 |
TWI577377B (zh) * | 2010-09-16 | 2017-04-11 | Viiv醫療保健公司 | 醫藥組合物 |
CN102258485A (zh) * | 2011-01-11 | 2011-11-30 | 北京润德康医药技术有限公司 | 一种含对乙酰氨基酚的注射用制剂及其应用 |
CN102600068A (zh) * | 2011-01-24 | 2012-07-25 | 联康药业克雷恩特塞提斯制药实验室有限责任公司 | 稳定即用的可注射扑热息痛制剂 |
-
2015
- 2015-11-17 SG SG11201704435PA patent/SG11201704435PA/en unknown
- 2015-11-17 UA UAA201706668A patent/UA122136C2/uk unknown
- 2015-11-17 MD MDA20170071A patent/MD20170071A2/ro not_active Application Discontinuation
- 2015-11-17 EP EP15816228.9A patent/EP3233055A1/en active Pending
- 2015-11-17 CU CUP2017000088A patent/CU20170088A7/es unknown
- 2015-11-17 TN TN2017000232A patent/TN2017000232A1/en unknown
- 2015-11-17 US US15/537,642 patent/US20180000940A1/en not_active Abandoned
- 2015-11-17 PE PE2017001066A patent/PE20171305A1/es unknown
- 2015-11-17 WO PCT/IB2015/058876 patent/WO2016097899A1/en active Application Filing
- 2015-11-17 CA CA2969303A patent/CA2969303A1/en not_active Abandoned
- 2015-11-17 JP JP2017533277A patent/JP2017538762A/ja active Pending
- 2015-11-17 KR KR1020177017759A patent/KR20170099911A/ko not_active Application Discontinuation
- 2015-11-17 AU AU2015365533A patent/AU2015365533A1/en not_active Abandoned
- 2015-11-17 EA EA201791409A patent/EA201791409A1/ru unknown
- 2015-11-17 CN CN201580069391.5A patent/CN107205924A/zh active Pending
- 2015-11-17 MX MX2017008264A patent/MX2017008264A/es unknown
- 2015-11-17 MA MA40599A patent/MA40599A1/fr unknown
- 2015-11-17 BR BR112017012975-2A patent/BR112017012975B1/pt active IP Right Grant
- 2015-11-27 TW TW104139783A patent/TWI649097B/zh not_active IP Right Cessation
- 2015-12-09 JO JOP/2015/0303A patent/JO3689B1/ar active
- 2015-12-21 AR ARP150104211A patent/AR103188A1/es unknown
- 2015-12-21 UY UY0001036466A patent/UY36466A/es unknown
-
2017
- 2017-05-31 PH PH12017501005A patent/PH12017501005A1/en unknown
- 2017-06-06 IL IL252729A patent/IL252729A0/en unknown
- 2017-06-09 DO DO2017000134A patent/DOP2017000134A/es unknown
- 2017-06-20 EC ECIEPI201738668A patent/ECSP17038668A/es unknown
- 2017-06-20 CL CL2017001629A patent/CL2017001629A1/es unknown
- 2017-06-23 CO CONC2017/0006268A patent/CO2017006268A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
MX2017008264A (es) | 2017-10-02 |
KR20170099911A (ko) | 2017-09-01 |
CL2017001629A1 (es) | 2018-03-16 |
JP2017538762A (ja) | 2017-12-28 |
MD20170071A2 (ro) | 2017-09-30 |
AU2015365533A1 (en) | 2017-07-06 |
ECSP17038668A (es) | 2017-12-01 |
PH12017501005A1 (en) | 2017-12-11 |
UA122136C2 (uk) | 2020-09-25 |
CU20170088A7 (es) | 2018-03-13 |
BR112017012975B1 (pt) | 2023-09-26 |
UY36466A (es) | 2016-07-29 |
EA201791409A1 (ru) | 2017-10-31 |
WO2016097899A1 (en) | 2016-06-23 |
TN2017000232A1 (en) | 2018-10-19 |
BR112017012975A2 (pt) | 2018-02-27 |
IL252729A0 (en) | 2017-08-31 |
TW201622703A (zh) | 2016-07-01 |
CN107205924A (zh) | 2017-09-26 |
CA2969303A1 (en) | 2016-06-23 |
AR103188A1 (es) | 2017-04-19 |
TWI649097B (zh) | 2019-02-01 |
MA40599A1 (fr) | 2017-11-30 |
JO3689B1 (ar) | 2020-08-27 |
CO2017006268A2 (es) | 2017-10-20 |
US20180000940A1 (en) | 2018-01-04 |
SG11201704435PA (en) | 2017-06-29 |
PE20171305A1 (es) | 2017-09-05 |
EP3233055A1 (en) | 2017-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202102906B (en) | Liquid protein formulations containing viscosity-lowering agents | |
AR107014A1 (es) | Formulación farmacéutica acuosa | |
SG10201902915VA (en) | Polysaccharide and nucleic acid formulations containing viscosity-lowering agents | |
CL2019002190A1 (es) | Reducción de la viscosidad de formulaciones farmacéuticas que comprende una proteína terapéutica a una concentración de al menos 70 mg/ml, donde la proteína terapéutica no es un anticuerpo (divisional solicitud 201700984) | |
MX2015012559A (es) | Novedosos fármacos de alta penetración y sus composiciones para el tratamiento de enfermedades de parkinson. | |
AR098386A1 (es) | Formulación para gonadotropinas | |
DOP2017000134A (es) | Formulaciones inyectables de paracetamol | |
PE20170426A1 (es) | Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo | |
PH12014502494A1 (en) | Parenteral esmolol formulation | |
EA201391512A1 (ru) | Твердая фармацевтическая композиция | |
RU2013142835A (ru) | Способ лечения ишемического инсульта | |
RU2014142874A (ru) | Способ лечения похмельного синдрома у лиц, не относящихся к больным алкоголизмом | |
EA201600331A1 (ru) | Фармацевтическая композиция в форме раствора для внутривенного и внутримышечного введения и способ ее получения | |
RU2013143983A (ru) | Способ коррекции иммунной недостаточности у инфицированного вирусом лейкоза крупного рогатого скота | |
EA201992500A2 (ru) | Соли и пролекарства 1-метил-d-триптофана | |
TH154084A (th) | สารละลายอะเซทามิโนเฟนที่ฉีดได้สำหรับการให้ทางไขสันหลัง | |
AR091633A1 (es) | Solucion inyectable de acetaminofen para su administracion por via espinal | |
TH155633A (th) | สูตรผสมแบบฉีดของเอสโมลอล | |
TH180780A (th) | สารละลายขยายม่านตา และต้านอาการอักเสบที่เสถียร ที่ปลอดจากสารกันบูด สำหรับการฉีด | |
RU2013119140A (ru) | Способ лечения вегетососудистой дистонии у детей и подростков |